
Geron Corp
GERNHealthcare|Biotechnology|USA
$1.50
-0.07 (-4.15%)
Tangible Book
$0.36
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812",
"202912",
"203012"
],
"revenue_estimate": [
233.75,
333.14,
486.17,
697.46,
918.71
],
"ebit_estimate": [
-1.83,
39.12,
92.96,
371.49,
575.63
],
"ebitda_estimate": [
-8.49,
-20.66,
-11.07,
null,
null
],
"net_income_estimate": [
-13.95,
47.9,
68.27,
234.57,
432.62
],
"per_share_eps_estimate": [
-0.02,
0.09,
0.25,
0.43,
0.64
],
"eps_nri_estimate": [
-0.02,
0.07,
0.19,
0.43,
0.64
],
"dividend_estimate": [
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-19.06,
46.9,
150.58,
363.17,
573.18
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
95.85,
96.3,
96.25,
96.5,
96.75
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null
],
"pettm_estimate": [
0,
16.3,
5.93,
3.53,
2.34
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "38.70",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": 38.7,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}
quarterly
{
"date": [
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
55.21,
59.85,
66.82,
77.29,
84.61,
92.19,
99.69
],
"ebit_estimate": [
-1.41,
-0.13,
2.17,
8.58,
14.02,
18.05,
20.84
],
"ebitda_estimate": [
-1.37,
-4.14,
-3.28,
null,
null,
null,
null
],
"net_income_estimate": [
-4.33,
-2.75,
-0.25,
5.43,
10.87,
14.65,
16.59
],
"per_share_eps_estimate": [
-0.01,
0,
0,
0.02,
0.03,
0.04,
0.04
],
"eps_nri_estimate": [
-0.01,
-0.01,
0,
0.02,
0.03,
0.04,
0.04
],
"dividend_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-4.06,
-2.72,
-0.61,
3.2,
7.7,
12.4,
11.7
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
95.9,
95.85,
95.3,
95,
95,
95,
97
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pettm_estimate": [
214.29,
35.71,
18.52,
12.1,
null,
null,
null
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "38.70",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": 38.7,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}